We then labeled synthetic peptides with TMT10plex-129N,130N, and 131 at concentrations of 10, 100, and 1000 fmol, respectively, and spiked into remaining purified MAPs from tissue samples that were labeled with TMT126 (NAT) and 127N (CRC). Here, BRD2 is linked to colorectal carcinoma.